Novo Nordisk A/S is one of the world's leading manufacturers of recombinant human growth hormone.
Human growth hormone is used to treat a variety of conditions in children and adults. It is prescribed to people who do not produce adequate levels of growth hormone on their own and is identical to what the body produces naturally.
Novo Nordisk is dedicated to furthering research into growth disorders and their treatment. We provide numerous services to help patients undergoing growth hormone treatment and their parents to live life to the full. Through an on-going dialogue with people who use our products and services, we constantly strive to improve the quality of what we offer.
This page is intended for members of the UK public
UK/WB/1013/0033(2) April 2016